Adis Journals
Browse
Summary Slide.png (34.02 kB)

Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload

Download (34.02 kB)
figure
posted on 2018-02-27, 15:50 authored by Jonathan Karnon, Keith Tolley, Joao Vieira, David Chandiwana
The full text can be found at:

https://link.springer.com/article/10.1007/s40261-012-0008-2

Funding

Novartis Pharmaceuticals

History

Usage metrics

    Clinical Drug Investigation

    Categories

    Keywords

    Iron OverloadDeferoxamineChelation TherapyEquipment CostDeferasirox

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC